Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.230
+0.105 (9.33%)
At close: Apr 25, 2025, 4:00 PM
1.240
+0.010 (0.81%)
Pre-market: Apr 28, 2025, 8:23 AM EDT
Quince Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$8.00
Upside
+550.41%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 → $4 | Strong Buy | Maintains | $12 → $4 | +225.20% | Mar 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +713.01% | Mar 24, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +875.61% | Feb 5, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +875.61% | Jan 2, 2025 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +631.71% | Dec 18, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +875.61% | Nov 14, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +875.61% | Nov 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +387.80% | Nov 7, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +794.31% | Oct 29, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +875.61% | Oct 22, 2024 |